HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 20 filers reported holding HCW BIOLOGICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,019 | -53.5% | 6,212 | +25.8% | 0.00% | – |
| Q1 2024 | $8,642 | +24.4% | 4,938 | -12.9% | 0.00% | – |
| Q4 2023 | $6,945 | -21.6% | 5,669 | +21.5% | 0.00% | – |
| Q3 2023 | $8,862 | +10.6% | 4,664 | +26.3% | 0.00% | – |
| Q2 2023 | $8,014 | +72754.5% | 3,693 | -53.5% | 0.00% | – |
| Q1 2023 | $11 | -15.4% | 7,948 | +16.5% | 0.00% | -100.0% |
| Q4 2022 | $13 | -99.9% | 6,820 | +6.2% | 0.00% | – |
| Q3 2022 | $15,000 | +87.5% | 6,424 | +73.8% | 0.00% | – |
| Q2 2022 | $8,000 | +300.0% | 3,696 | +493.3% | 0.00% | – |
| Q1 2022 | $2,000 | -88.9% | 623 | -89.3% | 0.00% | – |
| Q3 2021 | $18,000 | – | 5,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avantax Planning Partners, Inc. | 179,541 | $219,938 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,700 | $103,758 | 0.00% |
| Cresset Asset Management, LLC | 131,990 | $161,688 | 0.00% |
| WELLS FARGO & COMPANY/MN | 138 | $169 | 0.00% |
| NORTHERN TRUST CORP | 10,205 | $12,501 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 635 | $778 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 22,640 | $27,734 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 134,436 | $164,736 | 0.00% |
| BlackRock Inc. | 47,158 | $57,769 | 0.00% |